REDUCE-IT trial

Study / Research

A highly successful omega-3 trial using 4 grams of EPA (Vascepa), which showed a 25% reduction in cardiovascular events and identified the achieved omega-3 level as the strongest predictor of benefit.

Mentioned in 2 videos